Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Gruenberger

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|September 15, 2023
Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statementHossein Taghizadeh, Angela Djanani, Wolfgang Eisterer, et al.
Oncotarget|August 17, 2016
The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearanceLejla Alidzanovic, Patrick Starlinger, Dominic Schauer, et al.
Anticancer Research|October 7, 2017
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3Ewald Wöll, Josef Thaler, Felix Keil, et al.
Cancers|February 13, 2026
Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver MetastasesYawen Dong, Madita Tschoegl, Florian Lehner, et al.
Oncoimmunology|July 30, 2016
Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment responseDominic Schauer, Patrick Starlinger, Lejla Alidzanovic, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 5, 2016
Treatment sequence of synchronously (liver) metastasized colon cancerThomas Gruenberger, Geerard Beets, Jean-Luc Van Laethem, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 19, 2024
Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastasesBabette I Kuiper, Mohammad Abu Hilal, Luca A Aldrighetti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF<sup>V600E</sup>-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)Lena Weiss, Sebastian Stintzing, Dominik Paul Modest, et al.
Therapeutic Advances in Medical Oncology|April 22, 2020
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Austrian multicenter, noninterventional studyJakob Michael Riedl, Florian Posch, Gerald Prager, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 2020
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional studyGerald W Prager, Leopold Oehler, Armin Gerger, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|September 15, 2023
Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statementHossein Taghizadeh, Angela Djanani, Wolfgang Eisterer, et al.
Oncotarget|August 17, 2016
The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearanceLejla Alidzanovic, Patrick Starlinger, Dominic Schauer, et al.
Anticancer Research|October 7, 2017
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3Ewald Wöll, Josef Thaler, Felix Keil, et al.
Cancers|February 13, 2026
Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver MetastasesYawen Dong, Madita Tschoegl, Florian Lehner, et al.
Oncoimmunology|July 30, 2016
Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment responseDominic Schauer, Patrick Starlinger, Lejla Alidzanovic, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 5, 2016
Treatment sequence of synchronously (liver) metastasized colon cancerThomas Gruenberger, Geerard Beets, Jean-Luc Van Laethem, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 19, 2024
Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastasesBabette I Kuiper, Mohammad Abu Hilal, Luca A Aldrighetti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF<sup>V600E</sup>-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)Lena Weiss, Sebastian Stintzing, Dominik Paul Modest, et al.
Therapeutic Advances in Medical Oncology|April 22, 2020
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Austrian multicenter, noninterventional studyJakob Michael Riedl, Florian Posch, Gerald Prager, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 2020
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional studyGerald W Prager, Leopold Oehler, Armin Gerger, et al.
Pageof 4